Table 1.
Baseline patient characteristics
| Median (Interquartile Range) |
P Value | ||
|---|---|---|---|
| Placebo (N = 19) | GM-CSF (N = 25) | ||
| Age | 49 (35–58) | 50 (31–57.5) | 0.695 |
| Sex, % male | 63.1 | 52 | 0.55 |
| Etiology, % | 0.332 | ||
| Pneumonia | 26.3 | 28 | |
| Sepsis | 15.8 | 36 | |
| Aspiration | 5.3 | 16 | |
| Other | 42.1 | 20 | |
| Race, % | 0.308 | ||
| Caucasian | 63.2 | 80 | |
| Black | 36.8 | 12 | |
| Hispanic | 0 | 0 | |
| Other | 0 | 8 | |
| APACHE III | 51 (44–66) | 55 (44.5–66.5) | 0.635 |
| Steroid days | 0 (0–13) | 1 (0–17.5) | 0.526 |
| Ventilator-free days | 21 (10–24) | 15 (6–21) | 0.171 |
| Organ failure days | 6 (2–20) | 6 (1.5–18.5) | 0.905 |
Definition of abbreviations: APACHE = Acute Physiology and Chronic Health Evaluation; GM-CSF = granulocyte macrophage-colony stimulating factor.